Is Summit Therapeutics Inc. (SMMT) a Buy, Sell, or Hold?
NASDAQ : SMMT
Summit Therapeutics Inc. — Institutional Ownership
$13.66 USD
-$1.32 (-8.81%)
- Volume
- 8.15M
- Average Volume
- 5.25M
- Market Capitalization
- $10.6B
- P/E Ratio
- -12.20
- Dividend Yield
- 0.00%
- Price Target
- $23.00
- Year High
- $30.98
- Year Low
- $12.55
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $6.96
Institutional Ownership Summary
Institutional Ownership %
0.10%
Investors Holding
30
change: -210 | last: 240
Increased Positions
14
change: -127 | last: 141
Reduced Positions
7
change: -45 | last: 52
New Positions
5
change: -52 | last: 57
Sold Positions
200
change: 155 | last: 45
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -125.533 | last: 1.2553
Total Invested
11.43M
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2021-02-16 | Polar Capital Holdings Plc | 5.8M | 7.05% |
| 2021-02-16 | Polar Capital LLP | 5.8M | 7.05% |
| 2020-09-28 | ROBERT W. DUGGAN | 46.21M | 64.89% |
| 2020-09-28 | SHAUN ZANGANEH IRREVOCABLE TRUST | 2.42M | 3.58% |
| 2020-09-28 | MAHKAM ZANGANEH | 5.33M | 7.80% |
| 2020-09-28 | MAHKAM ZANGANEH REVOCABLE TRUST | 2.42M | 3.58% |
| 2020-01-23 | MAHKAM ZANGANEH | 24.2M | 7.14% |
| 2020-01-23 | SHAUN ZANGANEH IRREVOCABLE TRUST | 12.1M | 3.59% |
| 2020-01-23 | MAHKAM ZANGANEH REVOCABLE TRUST | 12.1M | 3.59% |
| 2020-01-16 | ROBERT W. DUGGAN | 231.05M | 64.94% |
| 2015-03-11 | Point72 Asset Management, L.P. | 3.86M | 6.60% |
| 2015-03-11 | Point72 Capital Advisors, Inc. | 3.86M | 6.60% |
| 2015-03-11 | Steven A. Cohen | 3.86M | 6.60% |
SMMT Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $17.49 | 747.7M | $13.08B | $167.18M | $15.5M | $12.93B |
| 2024-12-31 | $17.85 | 713.92M | $12.74B | $83.79M | $5.77M | $12.67B |
| 2023-12-31 | $2.61 | 619.64M | $1.62B | $56.52M | $83.96M | $1.64B |
| 2022-12-31 | $4.25 | 192.15M | $816.64M | $284.18M | $422.89M | $955.35M |
| 2021-12-31 | $2.69 | 92.24M | $248.12M | $53.22M | $2.06M | $196.97M |
| 2020-12-31 | $4.70 | 69.34M | $325.89M | $48.78M | $341.54K | $277.45M |
| 2019-12-31 | $1.21 | 32.73M | $39.48M | $49.96M | $699.64K | -$9.78M |
| 2019-01-31 | $1.01 | 86.14M | $87.38M | $35.23M | -$ | $52.16M |
| 2018-01-31 | $9.67 | 65.02M | $629M | $28.45M | -$ | $600.55M |
| 2017-01-31 | $8.32 | 61.06M | $508.21M | $35.08M | -$ | $473.13M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14.57 | 778.18M | $11.34B | $419.36M | $20.38M | $10.94B |
| 2026-03-31 | $18.96 | 775.46M | $14.7B | $80.78M | $15.2M | $14.64B |
| 2025-12-31 | $17.49 | 766.4M | $13.4B | $167.18M | $15.5M | $13.25B |
| 2025-09-30 | $20.66 | 743.42M | $15.36B | $177.33M | $4.03M | $15.19B |
| 2025-06-30 | $21.28 | 742.61M | $15.8B | $218.56M | $4.07M | $15.59B |
| 2025-03-31 | $19.29 | 699.04M | $13.48B | $163.84M | $5M | $13.33B |
| 2024-12-31 | $17.85 | 683.17M | $12.19B | $83.79M | $5.77M | $12.12B |
| 2024-09-30 | $21.90 | 703.18M | $15.4B | $71.54M | $24.79M | $15.35B |
| 2024-06-30 | $8.14 | 670.94M | $5.46B | $22.46M | $85.88M | $5.52B |
| 2024-03-31 | $3.98 | 701.79M | $2.79B | $48.83M | $87.25M | $2.83B |
| 2023-12-31 | $2.61 | 700.61M | $1.83B | $56.52M | $83.96M | $1.86B |
| 2023-09-30 | $1.87 | 697.75M | $1.3B | $19.56M | $87.67M | $1.37B |